Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes.

J Clin Transl Endocrinol · 2023 · PMC10336243 · PMID 37448650

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In conclusion, this retrospective study showed a trend towards improved glycemic control with lesser insulin doses, without concurrent severe hypoglycemias in patients with CFRD on combined CFTR modulators.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.